Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 2022

View Archived Issues

LONP1 targeting sensitizes therapy-resistant tumor cells to sorafenib

VesiVax Af3/9 vaccine protects against invasive pulmonary aspergillosis

Renovacor to advance AAV gene therapy program for arrhythmogenic cardiomyopathy

Beijing Innocare Medical Technology patents JAK inhibitors

MJFF grant supports evaluation of EpicentRx's NLRP3 inflammasome inhibitor for Parkinson's

Shanghai Visonpharma discloses new GTPase KRAS inhibitors

Galapagos NV presents new DDR inhibitors

Chinese researchers synthesize new GTPase KRAS inhibitors

Royal College of Surgeons in Ireland discloses HDAC6 inhibitors

Co-targeting MAPK and YAP-TEAD signaling as therapeutic strategy in melanoma

Targeting IL-33 release may be an approach for treating HCC

"Master sites" trigger cascade of tau phosphorylation in Alzheimer's disease

Novel genetic loci found for venous thromboembolism

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...